Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 3
1998 7
1999 2
2000 5
2001 5
2002 6
2003 6
2004 8
2005 8
2006 14
2007 12
2008 11
2009 17
2010 21
2011 25
2012 15
2013 18
2014 23
2015 20
2016 21
2017 17
2018 14
2019 21
2020 14
2021 7
2022 8
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

275 results

Results by year

Filters applied: . Clear all
Page 1
Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia.
Hochhaus A, Larson RA, Guilhot F, Radich JP, Branford S, Hughes TP, Baccarani M, Deininger MW, Cervantes F, Fujihara S, Ortmann CE, Menssen HD, Kantarjian H, O'Brien SG, Druker BJ; IRIS Investigators. Hochhaus A, et al. N Engl J Med. 2017 Mar 9;376(10):917-927. doi: 10.1056/NEJMoa1609324. N Engl J Med. 2017. PMID: 28273028 Free PMC article. Clinical Trial.
Relapse Prevention with Tyrosine Kinase Inhibitors after Allogeneic Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblast Leukemia: A Systematic Review.
Warraich Z, Tenneti P, Thai T, Hubben A, Amin H, McBride A, Warraich S, Hannan A, Warraich F, Majhail N, Kalaycio M, Anwer F. Warraich Z, et al. Among authors: kalaycio m. Biol Blood Marrow Transplant. 2020 Mar;26(3):e55-e64. doi: 10.1016/j.bbmt.2019.09.022. Epub 2019 Sep 23. Biol Blood Marrow Transplant. 2020. PMID: 31557532 Free article. Review.
Prolymphocytic leukemia.
Absi A, Hsi E, Kalaycio M. Absi A, et al. Among authors: kalaycio m. Curr Treat Options Oncol. 2005 May;6(3):197-208. doi: 10.1007/s11864-005-0003-4. Curr Treat Options Oncol. 2005. PMID: 15869731 Review.
Your patient has chronic leukemia: Now what?
Kalaycio M. Kalaycio M. Cleve Clin J Med. 2016 Aug;83(8):575-81. doi: 10.3949/ccjm.83gr.16002. Cleve Clin J Med. 2016. PMID: 27505878 Free article. Review.
Monoclonal gammopathy of undetermined significance: A primary care guide.
Khouri J, Samaras C, Valent J, Mejia Garcia A, Faiman B, Mathur S, Hamilton K, Nakashima M, Kalaycio M. Khouri J, et al. Among authors: kalaycio m. Cleve Clin J Med. 2019 Jan;86(1):39-46. doi: 10.3949/ccjm.86a.17133. Cleve Clin J Med. 2019. PMID: 30624183 Free article. Review.
Inpatient management of acute leukemia.
Kalaycio M. Kalaycio M. Cleve Clin J Med. 1997 Jul-Aug;64(7):385-9. doi: 10.3949/ccjm.64.7.385. Cleve Clin J Med. 1997. PMID: 9223768 Free article. Review.
Tacrolimus/methotrexate vs tacrolimus/reduced-dose methotrexate/mycophenolate for graft-versus-host disease prevention.
Hamilton BK, Rybicki LA, Li H, Lucas T, Corrigan D, Kalaycio M, Sobecks R, Hanna R, Rotz SJ, Dean RM, Gerds AT, Jagadeesh D, Brunstein C, Sauter CS, Copelan EA, Majhail NS. Hamilton BK, et al. Among authors: kalaycio m. Blood Adv. 2023 Aug 22;7(16):4505-4513. doi: 10.1182/bloodadvances.2023010310. Blood Adv. 2023. PMID: 37352262 Free PMC article. Clinical Trial.
Reply to A. Piccardo et al, E. Hindié et al, M.C. Kreissl et al, M. Doss, J. Buscombe, R. Fisher, M. Sollini et al, M. Lichtenstein, and M. Tulchinsky et al.
Molenaar RJ, Sidana S, Radivoyevitch T, Gerds AT, Carraway HE, Kalaycio M, Nazha A, Adelstein DJ, Nasr C, Maciejewski JP, Majhail NS, Sekeres MA, Mukherjee S. Molenaar RJ, et al. Among authors: kalaycio m. J Clin Oncol. 2018 Jun 20;36(18):1889-1892. doi: 10.1200/JCO.2018.78.4074. Epub 2018 May 3. J Clin Oncol. 2018. PMID: 29723096 No abstract available.
275 results